Through the above bioinformatics analysis, as well as the detection results in clinical glioma samples, we found that TSPAN7 gradually decreased with increasing tumor grade, and higher TSPAN7 expression was associated with a better prognosis. The gene discussed is TSPAN7; the disease is central nervous system cancer.